The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 07, 2015

Filed:

Apr. 21, 2009
Applicants:

Keiji Inoue, Nankoku, JP;

Masahiro Ishizuka, Saitama, JP;

Tohru Tanaka, Kita-adachi-gun, JP;

Inventors:

Keiji Inoue, Nankoku, JP;

Masahiro Ishizuka, Saitama, JP;

Tohru Tanaka, Kita-adachi-gun, JP;

Assignees:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); A61K 31/198 (2006.01); A61K 41/00 (2006.01);
U.S. Cl.
CPC ...
A61K 49/0021 (2013.01); A61K 41/0061 (2013.01); Y10S 514/814 (2013.01);
Abstract

Provided is a sensitizing detection agent of an oral or intravenous administration type which enables the detection of bladder cancer with a higher sensitivity without causing pain to the patient. A sensitizing detection agent for bladder cancer comprising 5-aminolevulinic acid (ALA), a derivative thereof, or a salt of these is orally or intravenously administered, and a video camera system is inserted via the urethra and a blue light at 380-440 nm is irradiated to observe the red fluorescent part. Further, VLD-M1 is inserted and a blue light at 405 nm is irradiated to observe fluorescence intensity (relative intensity) of the red light part. For oral administration, 20 mg/kg (maximum of 1 g) of ALA is dissolved in 50 mL of a 5% glucose solution prior to the administration.


Find Patent Forward Citations

Loading…